• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec9
U.S. Bank Raises Ionis Pharmaceuticals Target Price to $97
18:17
Dec4
Ionis Pharmaceuticals Director Sold Company Common Stock
00:01
Dec1
Ionis Pharmaceuticals Receives FDA Breakthrough Therapy Designation
12:01
Nov28
Ionis Pharmaceuticals Director Disposes of Company Common Stock
22:52
Ionis Pharmaceuticals EVP and CHRO Shannon L. Devers Sells Common Stock
22:52
Nov17
Ionis Pharmaceuticals Announces $700 Million Convertible Senior Notes Offering
21:07

Schedules & Filings

Schedules
Filings
Oct29
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 156.72 M, Net Income -128.61 M, EPS -0.8049

Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 452.05 M, Net Income 123.55 M, EPS 0.7

Apr30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 131.61 M, Net Income -146.94 M, EPS -0.9256

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More